News
The CBR goes Dragon Boat Racing!
July 27, 2017
The CBR enjoyed a lively outing on False Creek to go Dragon Boating! Members from the Conway lab and the Hancock lab engaged in close competition during four boat races, after perfecting their rowing techniques.
Dr. Chris Overall wins 2017 HUPO Award
July 24, 2017
The Human Proteome Organization (HUPO) recognized Dr. Chris Overall for his outstanding accomplishments and contributions to the field of proteomics. Congratulations to Dr. Overall and his team on winning the 2017 Discovery in Proteomic Sciences Award!
Transfusion Medicine “Boot-Less” Camp
July 20, 2017
Narrowing the transfusion knowledge gap among physicians and residents is critical to improving patient outcomes. “Transfusion Camp” is a new program that is targeting this gap and having far-reaching effects.
Kastrup Lab Uses Simulations to Uncover a Potential New Player in Thrombosis
July 17, 2017
Researchers from the Kastrup Lab at the CBR have provided insight into the mechanism of action for one activator involved in blood clot formation: short‑chain polyphosphate (PolyP).
Bromme Lab Makes an Osteoporosis Mouse Model that is More Similar to Humans
June 29, 2017
All new osteoporosis drugs have failed clinical trials with unexpected severe side effects and no one knew the reason. Now, Bromme Lab at the CBR discovered key differences between mouse and human cathepsin K proteins that can help create more effective mouse models and test for side-effects long before human trials.
CBR Members Receive Prestigious CIHR Awards
June 22, 2017
All levels of researchers at the Centre for Blood Research, UBC, have received CIHR awards in the 2016-2017 cycle.
CBR Amazing Race – one-of-a-kind Science Event
June 15, 2017
Under the slogan “Summer Students Run. CBR Members Host”, fifteen CBR labs on campus united to host a one-of-a-kind science gaming event for the summer students on a Friday afternoon last week.
5 Things I Learned From the 5th Canadian Obesity Summit
June 9, 2017
Obesity is a multi-faceted disease with an abundance of overlapping metabolic, genetic and lifestyle factors that contribute to its significant prevalence in the community.
Kizhakkedathu Lab Develops Heparin Reversal Treatment Without Usual Side-Effects
May 31, 2017
Published in Blood, Dr. Manu Kalathottukaren showed that the Universal Heparin Reversal Agent (UHRA) developed in Dr. Kizhakkedathu’s Lab is non-toxic and has many advantages over the current standard of treatment.
CBR Researchers Achieve near Atomic Resolution of Salmonella’s Nano-Syringe
May 26, 2017
How do pathogenic bacteria manipulate host cells and cause disease? Published in Nature, Dr Strynadka’s lab at CBR solved the structure of the “nano-syringe” Salmonella uses to infect the host and cause disease.